E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-barr virus C promoter, EBNA1 and orip, participating in long-distance promoter-enhancer interactions

Journal of General Virology

Volumn 93, Issue 5, 2012, Pages 1065-1075

  Boreström, Cecilia ^a   Forsman, Alma ^a   Rüetschi, Ulla ^a   Rymo, Lars ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; EPSTEIN BARR VIRUS ANTIGEN 1; OCTAMER TRANSCRIPTION FACTOR 2; PROTEIN ARID3A; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ARTICLE; DNA REPLICATION ORIGIN; ENHANCER REGION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS C PROMOTER; NONHUMAN; NUCLEOTIDE REPEAT; ORIGIN OF PLASMID REPLICATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; TRANSCRIPTION INITIATION;

CHROMATOGRAPHY, AFFINITY; DNA, VIRAL; DNA-BINDING PROTEINS; E2F1 TRANSCRIPTION FACTOR; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MASS SPECTROMETRY; OCTAMER TRANSCRIPTION FACTOR-2; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN MULTIMERIZATION; REPLICATION ORIGIN; TRANSCRIPTION FACTORS;

HUMAN HERPESVIRUS 4;

EID: 84859852702     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.038752-0     Document Type: Article

References (45)

1. Almqvist, J., Zou, J., Linderson, Y., Borestrom, C., Altiok, E., Zetterberg, H., Rymo, L., Pettersson, S. & Ernberg, I. (2005). Functional interaction of Oct transcription factors with the family of repeats in Epstein-Barr virus oriP. J Gen Virol 86, 1261-1267.
2. Atanasiu, C., Lezina, L. & Lieberman, P. M. (2005). DNA affinity purification of Epstein-Barr virus OriP-binding proteins. Methods Mol Biol 292, 267-276.
3. Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C. & other authors (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207-211.
4. Boreströ m, C., Zetterberg, H., Liff, K. & Rymo, L. (2003). Functional interaction of nuclear factor Y and Sp1 is required for activation of the Epstein-Barr virus C promoter. J Virol 77, 821-829.
5. Chau, C. M., Zhang, X. Y., McMahon, S. B. & Lieberman, P. M. (2006). Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J Virol 80, 5723-5732.
6. Chau, C. M., Deng, Z., Kang, H. & Lieberman, P. M. (2008). Cell cycle association of the retinoblastoma protein Rb and the histone demethylase LSD1 with the Epstein-Barr virus latency promoter Cp. J Virol 82, 3428-3437.
7. Daikoku, T., Kudoh, A., Fujita, M., Sugaya, Y., Isomura, H. & Tsurumi, T. (2004). In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus. J Biol Chem 279, 54817-54825.
8. Davenport, M. G. & Pagano, J. S. (1999). Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. J Virol 73, 3154-3161.
9. Deutsch, M. J., Ott, E., Papior, P. & Schepers, A. (2010). The latent origin of replication of Epstein-Barr virus directs viral genomes to active regions of the nucleus. J Virol 84, 2533-2546.
10. Farré, D., Roset, R., Huerta, M., Adsuara, J. E., Roselló, L., Albà, M. M. & Messeguer, X. (2003). Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res 31, 3651-3653.
11. Forsman, A., Rüetschi, U., Ekholm, J. & Rymo, L. (2008). Identification of intracellular proteins associated with the EBVencoded nuclear antigen 5 using an efficient TAP procedure and FTICR mass spectrometry. J Proteome Res 7, 2309-2319.
12. Frappier, L. & O'Donnell, M. (1991). Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc Natl Acad Sci U S A 88, 10875-10879.
13. Fuentes-Pananá, E. M., Peng, R., Brewer, G., Tan, J. & Ling, P. D. (2000). Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway. J Virol 74, 8166-8175.
14. Fukuyo, Y., Mogi, K., Tsunematsu, Y. & Nakajima, T. (2004). E2FBP1/ hDril1 modulates cell growth through downregulation of promyelocytic leukemia bodies. Cell Death Differ 11, 747-759.
15. Gregory, C. D., Rowe, M. & Rickinson, A. B. (1990). Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 71, 1481-1495.
16. Grossman, S. R., Johannsen, E., Tong, X., Yalamanchili, R. & Kieff, E. (1994). The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad Sci U S A 91, 7568-7572.
17. Herrscher, R. F., Kaplan, M. H., Lelsz, D. L., Das, C., Scheuermann, R. & Tucker, P. W. (1995). The immunoglobulin heavy-chain matrixassociating regions are bound by Bright: a B cell-specific transactivator that describes a new DNA-binding protein family. Genes Dev 9, 3067-3082.
18. Ivanova, I. A., Vespa, A. & Dagnino, L. (2007). A novel mechanism of E2F1 regulation via nucleocytoplasmic shuttling: determinants of nuclear import and export. Cell Cycle 6, 2186-2195.
19. Jarvius, M., Paulsson, J., Weibrecht, I., Leuchowius, K. J., Andersson, A. C., Wählby, C., Gullberg, M., Botling, J., Sjö blom, T. & other authors (2007). In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method. Mol Cell Proteomics 6, 1500-1509.
20. Jin, X. W. & Speck, S. H. (1992). Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. J Virol 66, 2846-2852.
21. Kanda, T., Kamiya, M., Maruo, S., Iwakiri, D. & Takada, K. (2007). Symmetrical localization of extrachromosomally replicating viral genomes on sister chromatids. J Cell Sci 120, 1529-1539.
22. Kaplan, M. H., Zong, R. T., Herrscher, R. F., Scheuermann, R. H. & Tucker, P. W. (2001). Transcriptional activation by a matrix associating region-binding protein. Contextual requirements for the function of Bright. J Biol Chem 276, 21325-21330.
23. Kieff, E. & Rickinson, A. B. (2001). Epstein-Barr virus and its replication. In Fields Virology, 4th edn, vol. 2, pp. 2511-2574. Edited by D. M. Knipe, P. M. Howley, D. E. Griffin, M. A. Martin, R. A. Lamb, B. Roizman & S. E. Straus. Philadelphia, PA: Lippincott Williams & Wilkins.
24. Kim, D. & Tucker, P. W. (2006). A regulated nucleocytoplasmic shuttle contributes to Bright's function as a transcriptional activator of immunoglobulin genes. Mol Cell Biol 26, 2187-2201.
25. Ling, P. D., Rawlins, D. R. & Hayward, S. D. (1993). The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc Natl Acad Sci U S A 90, 9237-9241.
26. Mackey, D. & Sugden, B. (1999). The linking regions of EBNA1 are essential for its support of replication and transcription. Mol Cell Biol 19, 3349-3359.
27. Maruo, S., Johannsen, E., Illanes, D., Cooper, A., Zhao, B. & Kieff, E. (2005). Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jk/ CBF1 is critical. J Virol 79, 10171-10179.
28. Maser, R. S., Mirzoeva, O. K., Wells, J., Olivares, H., Williams, B. R., Zinkel, R. A., Farnham, P. J. & Petrini, J. H. (2001). Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol Cell Biol 21, 6006-6016.
29. Messeguer, X., Escudero, R., Farré, D., Núñez, O., Martínez, J. & Albà, M. M. (2002). PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18, 333-334.
30. Nelson, J. D., Denisenko, O. & Bomsztyk, K. (2006). Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc 1, 179-185.
31. Niedojadlo, J., Perret-Vivancos, C., Kalland, K. H., Cmarko, D., Cremer, T., van Driel, R. & Fakan, S. (2011). Transcribed DNA is preferentially located in the perichromatin region of mammalian cell nuclei. Exp Cell Res 317, 433-444.
32. Nilsson, T., Sjöblom, A., Masucci, M. G. & Rymo, L. (1993). Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype. Virology 193, 774-785.
33. Nilsson, T., Zetterberg, H., Wang, Y. C. & Rymo, L. (2001). Promoterproximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in Blymphoid cell lines. J Virol 75, 5796-5811.
34. Nixon, J. C., Rajaiya, J. B., Ayers, N., Evetts, S. & Webb, C. F. (2004). The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations. Cell Immunol 228, 42-53.
35. Paulson, E. J., Fingeroth, J. D., Yates, J. L. & Speck, S. H. (2002). Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells. Virology 299, 109-121.
36. Rickinson, A. B. & Kieff, E. (2001). Epstein-Barr virus. In Fields Virology, 4th edn, vol. 2, pp. 2575-2627. Edited by D. M. Knipe, P. M. Howley, D. E. Griffin, M. A. Martin, R. A. Lamb, B. Roizman & S. E. Straus. Philadelphia, PA: Lippincott Williams & Wilkins.
37. Sample, J., Henson, E. B. & Sample, C. (1992). The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J Virol 66, 4654-4661.
38. Sö derberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K. J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F. & other authors (2006). Direct observation of individual endogenous protein complexes in situ by proximity ligation. NatMethods 3, 995-1000.
39. Sung, N. S., Kenney, S., Gutsch, D. & Pagano, J. S. (1991). EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. J Virol 65, 2164-2169.
40. Suzuki, M., Okuyama, S., Okamoto, S., Shirasuna, K., Nakajima, T., Hachiya, T., Nojima, H., Sekiya, S. & Oda, K. (1998). A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer. Oncogene 17, 853-865.
41. Tempera, I., Klichinsky, M. & Lieberman, P. M. (2011). EBV latency types adopt alternative chromatin conformations. PLoS Pathog 7, e1002180.
42. Webb, C. F., Das, C., Eaton, S., Calame, K. & Tucker, P. W. (1991). Novel protein-DNA interactions associated with increased immunoglobulin transcription in response to antigen plus interleukin-5. Mol Cell Biol 11, 5197-5205.
43. Webb, C. F., Smith, E. A., Medina, K. L., Buchanan, K. L., Smithson, G. & Dou, S. (1998). Expression of Bright at two distinct stages of B lymphocyte development. J Immunol 160, 4747-4754.
44. Zeng, P. Y., Vakoc, C. R., Chen, Z. C., Blobel, G. A. & Berger, S. L. (2006). In vivo dual cross-linking for identification of indirect DNA-associated proteins by chromatin immunoprecipitation. Biotechniques 41, 694-698.
45. Zetterberg, H., Boreströ m, C., Nilsson, T. & Rymo, L. (2004). Multiple EBNA1-binding sites within oriPI are required for EBNA1-dependent transactivation of the Epstein-Barr virus C promoter. Int J Oncol 25, 693-696.